Author: Heechang Compiled by: TechFlow xStocks offers a tokenized stock service, allowing investors to trade tokenized versions of popular US stocks like Tesla in real time. While still in its early stages, it’s already showing some interesting signs of growth. Observation 1: Trading is concentrated in Tesla (TSLA) As in many emerging markets, trading activity has quickly concentrated on a handful of stocks. Data shows a high concentration of trading volume in the most well-known and volatile stocks, with Tesla being the most prominent example. This concentration is not surprising: liquidity tends to accumulate in assets that retail investors already favor, and early adopters often use familiar high-beta stocks to test new infrastructure. Observation 2: Liquidity decreases on weekends Data shows that on-chain equity trading volume drops to 30% or less of weekday levels over the weekend. Unlike crypto-native assets, which trade seamlessly around the clock, tokenized stocks still inherit the behavioral inertia of traditional market trading hours. Traders appear less willing to trade when reference markets (such as Nasdaq and the New York Stock Exchange) are closed, likely due to concerns about arbitrage, price gaps, and the inability to hedge positions off-chain. Observation 3: Prices move in line with the Nasdaq Another key signal comes from pricing behavior during the initial launch period. Initially, xStocks tokens traded at a significant premium to their Nasdaq counterparts, reflecting market enthusiasm and potential friction in bridging fiat liquidity. However, these premiums gradually diminished over time. Current trading patterns show that the token price is at the upper limit of Tesla's intraday price range and is highly consistent with the Nasdaq reference price. Arbitrageurs appear to be maintaining this price discipline, but there are still small deviations from the intraday highs, indicating some market inefficiencies that may present opportunities and risks for active traders. New opportunities for Korean stock investors? South Korean investors currently hold over $100 billion in US stocks, with trading volume increasing 17-fold since January 2020. Existing infrastructure for South Korean investors to trade US stocks is limited by high fees, long settlement times, and slow cash-out processes, creating opportunities for tokenized or on-chain mirror stocks. As the infrastructure and platforms supporting on-chain US stock markets continue to improve, a new group of South Korean traders will enter the crypto market, which is undoubtedly a huge opportunity.Author: Heechang Compiled by: TechFlow xStocks offers a tokenized stock service, allowing investors to trade tokenized versions of popular US stocks like Tesla in real time. While still in its early stages, it’s already showing some interesting signs of growth. Observation 1: Trading is concentrated in Tesla (TSLA) As in many emerging markets, trading activity has quickly concentrated on a handful of stocks. Data shows a high concentration of trading volume in the most well-known and volatile stocks, with Tesla being the most prominent example. This concentration is not surprising: liquidity tends to accumulate in assets that retail investors already favor, and early adopters often use familiar high-beta stocks to test new infrastructure. Observation 2: Liquidity decreases on weekends Data shows that on-chain equity trading volume drops to 30% or less of weekday levels over the weekend. Unlike crypto-native assets, which trade seamlessly around the clock, tokenized stocks still inherit the behavioral inertia of traditional market trading hours. Traders appear less willing to trade when reference markets (such as Nasdaq and the New York Stock Exchange) are closed, likely due to concerns about arbitrage, price gaps, and the inability to hedge positions off-chain. Observation 3: Prices move in line with the Nasdaq Another key signal comes from pricing behavior during the initial launch period. Initially, xStocks tokens traded at a significant premium to their Nasdaq counterparts, reflecting market enthusiasm and potential friction in bridging fiat liquidity. However, these premiums gradually diminished over time. Current trading patterns show that the token price is at the upper limit of Tesla's intraday price range and is highly consistent with the Nasdaq reference price. Arbitrageurs appear to be maintaining this price discipline, but there are still small deviations from the intraday highs, indicating some market inefficiencies that may present opportunities and risks for active traders. New opportunities for Korean stock investors? South Korean investors currently hold over $100 billion in US stocks, with trading volume increasing 17-fold since January 2020. Existing infrastructure for South Korean investors to trade US stocks is limited by high fees, long settlement times, and slow cash-out processes, creating opportunities for tokenized or on-chain mirror stocks. As the infrastructure and platforms supporting on-chain US stock markets continue to improve, a new group of South Korean traders will enter the crypto market, which is undoubtedly a huge opportunity.

How is the xStocks tokenized stock market developing?

2025/09/18 08:00

Author: Heechang

Compiled by: TechFlow

xStocks offers a tokenized stock service, allowing investors to trade tokenized versions of popular US stocks like Tesla in real time. While still in its early stages, it’s already showing some interesting signs of growth.

Observation 1: Trading is concentrated in Tesla (TSLA)

As in many emerging markets, trading activity has quickly concentrated on a handful of stocks. Data shows a high concentration of trading volume in the most well-known and volatile stocks, with Tesla being the most prominent example.

This concentration is not surprising: liquidity tends to accumulate in assets that retail investors already favor, and early adopters often use familiar high-beta stocks to test new infrastructure.

Observation 2: Liquidity decreases on weekends

Data shows that on-chain equity trading volume drops to 30% or less of weekday levels over the weekend. Unlike crypto-native assets, which trade seamlessly around the clock, tokenized stocks still inherit the behavioral inertia of traditional market trading hours. Traders appear less willing to trade when reference markets (such as Nasdaq and the New York Stock Exchange) are closed, likely due to concerns about arbitrage, price gaps, and the inability to hedge positions off-chain.

Observation 3: Prices move in line with the Nasdaq

Another key signal comes from pricing behavior during the initial launch period. Initially, xStocks tokens traded at a significant premium to their Nasdaq counterparts, reflecting market enthusiasm and potential friction in bridging fiat liquidity. However, these premiums gradually diminished over time.

Current trading patterns show that the token price is at the upper limit of Tesla's intraday price range and is highly consistent with the Nasdaq reference price.

Arbitrageurs appear to be maintaining this price discipline, but there are still small deviations from the intraday highs, indicating some market inefficiencies that may present opportunities and risks for active traders.

New opportunities for Korean stock investors?

South Korean investors currently hold over $100 billion in US stocks, with trading volume increasing 17-fold since January 2020. Existing infrastructure for South Korean investors to trade US stocks is limited by high fees, long settlement times, and slow cash-out processes, creating opportunities for tokenized or on-chain mirror stocks. As the infrastructure and platforms supporting on-chain US stock markets continue to improve, a new group of South Korean traders will enter the crypto market, which is undoubtedly a huge opportunity.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

The post New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million  appeared on BitcoinEthereumNews.com. One of the most talked-about ecosystems in the cryptocurrency space is the XRP Ledger (XRPL), and DeXRP, the first Presale on XRPL, recently made headlines for its growth story. Attracting over 9,300 investors globally, the project has now raised over $6.4 million and is rapidly emerging as one of the most viral cryptocurrency launches of 2025. By integrating AMM and Order Book trading with a cutting-edge LP system and an open voting process for holders, DeXRP hopes to establish itself as the preferred trading destination for the XRPL community. What is DeXRP?  As the first decentralized exchange (DEX) based on XRPL, DeXRP is taking center stage as XRP continues to solidify its place in the global market. Massive expectation has been generated by the combination of DeXRP’s ambition for an advanced trading platform and XRPL’s established infrastructure, which is renowned for its quick transactions, cheap fees, and institutional-ready capabilities. In contrast to a lot of speculative presales, DeXRP’s development shows both institutional interest and community-driven momentum. Its early achievement of the $6.4 million milestone demonstrates how rapidly investors are realizing its potential. DeXRP Presale Success More than 9,300 distinct wallets have already joined the DeXRP presale, indicating a high level of interest from around the world. A crucial aspect is highlighted by the volume and variety of participation: DeXRP is not merely a niche project; rather, it is emerging as a major force in the XRPL ecosystem. DeXRP’s recent collaborations with WOW Earn and Micro3, as well as its sponsorship of the WOW Summit in Hong Kong, are also contributing factors to this uptick in investor confidence. These actions are blatant attempts to increase the company’s awareness among institutional players and crypto-native groups. The Forbes article summed it up: DeXRP is embedding credibility where others chase hype, marking it as…
Share
2025/09/18 20:14
Share
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
2025/09/18 05:26
Share